uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Helicobacter pylori and gastrointestinal symptoms in diagnostics and adjuvant chemotherapy of colorectal cancer
Show others and affiliations
2014 (English)In: Oncology Letters, ISSN 1792-1074, Vol. 7, no 2, 553-559 p.Article in journal (Refereed) Published
Abstract [en]

5-Fluorouracil (5-FU)-based chemotherapy is the mainstay of adjuvant treatment for colorectal cancer (CRC). Few studies have explored Helicobacter pylori (H. pylori)-associated gastrointestinal symptoms in the diagnosis of CRC, and the association between H. pylori infection and gastrointestinal toxicity during adjuvant chemotherapy in CRC. Seventy-nine CRC patients were randomised in a prospective clinical trial to receive 5-FU and leucovorin administered as bolus injection (Mayo regimen) or continuous infusion (simplified de Gramont regimen). H. pylori antibodies were analysed at baseline, twice monthly during treatment and after treatment up to 12 months. Thirty-seven patients (47%) were H. pylori-seronegative at baseline. There was no significant association between baseline H. pylori seropositivity (n=42; 53%) and oro-gastrointestinal toxicity during chemotherapy. The median time from symptom onset of CRC to surgery was significantly longer in patients with H. pylori infection (median time, 6 vs. 5 months; P=0.012). Functional dyspeptic symptoms at presentation significantly delayed diagnosis (median time, 7.5 vs. 5 months; P=0.035), whereas anaemia, bowel symptoms, occlusion, blood in the stool, infection and hypolactasia did not. We conclude that there is no association between H. pylori status and gastrointestinal toxicity in CRC patients during chemotherapy. Dyspeptic symptoms and presence of H. pylori may delay the diagnosis of CRC. (www.controlled-trials.com/ISRCTN98405441).

Place, publisher, year, edition, pages
2014. Vol. 7, no 2, 553-559 p.
Keyword [en]
adjuvant treatment, colorectal cancer, gastrointestinal symptoms, Helicobacter pylori
National Category
Cancer and Oncology
URN: urn:nbn:se:uu:diva-227136DOI: 10.3892/ol.2013.1714ISI: 000332693400050OAI: oai:DiVA.org:uu-227136DiVA: diva2:728738
Available from: 2014-06-24 Created: 2014-06-24 Last updated: 2014-06-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Rautelin, Hilpi
By organisation
Clinical Microbiology and Infectious Medicine
In the same journal
Oncology Letters
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 171 hits
ReferencesLink to record
Permanent link

Direct link